High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade

Clinical Trial ID: NCT03162432

The goal of this study will be to assess the safety and efficacy of high-dose interval Vitamin D3 therapy in children and young adults with Inflammatory Bowel Disease being treated with serial Remicade infusions.

Study subjects will receiving 50,000 units of Vitamin D3 if they receive Remicade infusions every 4-6 weeks. Study subjects will receiving 100,000 units of Vitamin D3 if they receive Remicade infusions every 6-8 weeks.

Inclusion Criteria: - Existing diagnosis of IBD - Age 0-25 years - Measured serum level of 25-OH Vitamin D of 15-29 ng/ml in the last 8 weeks and no changes in Vitamin D supplementation in the interim Exclusion Criteria: - Pregnant Women - History of underlying kidney disease - History of granulomatous disease - Inability to take oral Vitamin D - History of hypercalcemia or hypercalciuria - Currently taking an anti-epileptic medication - History of pre-existing liver disease (excluding primary sclerosing cholangitis, non-alcoholic fatty liver disease, or steatohepatitis)

Start Date
2017-08-01
Last Updated
2018-05-24
Sponsor
Boston Children’s Hospital
Condition Name
Crohn Disease

Learn about this trial.

Check the eligibility requirements, study details, and more.

Visit clinicaltrials.gov

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.

Clinicaltrials.gov

Pilot Study of Fundamental Modification of the Gut Microbiota in the...

The purpose of this study is to determine the effect of a novel gut microbiota-targeted therapeutic regimen (bowel lavage and antibiotics with or without an antifungal) in the management of active Crohn's...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Clinicaltrials.gov

Triple Combination Therapy in High Risk Crohn's Disease (CD)

The purpose of this study is to determine the effect of triple combination therapy with an anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor (TNF) antagonist (adalimumab subcutaneously...

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Takeda

Clinicaltrials.gov

Autologous Stem Cell Transplantation for Crohn's Disease

The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC) in pediatric...

Trial Type

Interventional

Trial Phase

Phase 1/Phase 2

Sponsorship

Paul Szabolcs

Clinicaltrials.gov

Vedolizumab Subcutaneous Long-Term Open-Label Extension Study

The purpose of this study is to obtain long term safety and tolerability data of vedolizumab subcutaneous (vedolizumab SC) in participants with ulcerative colitis (UC) and Crohn's disease (CD).

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

Takeda

Clinicaltrials.gov

Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason

The investigators plan to compare contrast-enhanced ultrasound to CT and MRI for the detection and quantification of intestinal inflammation in the the setting of pediatric small bowel Crohns disease

Trial Type

Observational

Sponsorship

Children's Hospital Medical Center, Cincinnati

Clinicaltrials.gov

Fecal Microbial Transplantation in Patients With Crohn's Disease

Fecal Microbiota Transplantation will be offered to eligible Crohn's disease patient as Investigational New Drug treatment

Trial Type

Interventional

Trial Phase

Early Phase 1

Sponsorship

Stony Brook University

Clinicaltrials.gov

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely active Crohn's disease (CD) who have previously...

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

Janssen Scientific Affairs, LLC

Clinicaltrials.gov

Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the...

The purpose of this phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived...

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

Tigenix S.A.U.

Clinicaltrials.gov

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric...

The purpose of this study is to determine the safety profile of long-term vedolizumab IV treatment in pediatric participants with UC or CD.

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Takeda

Clinicaltrials.gov

Early MRI Prediction of Crohns

The investigators plan a prospective study designed to optimize and translate noncontrast, novel Magnetic Resonance Imaging (MRI) techniques for detecting and measuring intestinal inflammation as well as for...

Trial Type

Observational

Sponsorship

Children's Hospital Medical Center, Cincinnati

Clinicaltrials.gov

Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to...

This study will evaluate the efficacy of capsule endoscopy (CE) versus ileocolonoscopy (IC) plus MRE for detection of active Crohn's disease (CD) in the small bowel in subjects with known CD and mucosal...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Medtronic - MITG

Clinicaltrials.gov

Efficacy and Safety of TD-1473 in Crohn's Disease

A Phase 2 study to evaluate the efficacy, safety and tolerability of TD-1473 in subjects with moderately-to-severely active Crohn's Disease with up to 36 weeks of treatment.

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Theravance Biopharma

Clinicaltrials.gov

Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease

Recent data suggest that diet in inflammatory bowel disease (IBD) may lead to both symptom control and disease remission. Historically certain diets have been recommended for patients with Crohn's disease...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

University of Washington

Clinicaltrials.gov

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug...

The purpose of this study is to evaluate in a step-wise approach the disease drug-drug interaction (DDI) potential for vedolizumab to indirectly affect the exposure of cytochrome P-450 (CYP) substrate drugs by...

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Takeda

Clinicaltrials.gov

Corticosteroid Dosage for Crohn's Disease Flare

Prospective randomized comparative effectiveness trial designed to compare fixed dosing and weight-based dosing of corticosteroids in patients with Crohn's disease flares.

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Yale University

Clinicaltrials.gov

Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E....

This study will evaluate the safety of oral administration of EcoActive to patients with inactive Crohn's disease and how it affects the levels of AIEC in stool.

Trial Type

Interventional

Trial Phase

Phase 1/Phase 2

Sponsorship

MOUNT SINAI HOSPITAL

Clinicaltrials.gov

Autologous Stem Cell Transplant for Crohn's Disease

Crohn's Disease (CD) is an inflammatory bowel disease. It can lead to significant complications and discomfort in the stomach and intestines. Crohn's disease is a debilitating, incurable disease of immune...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Icahn School of Medicine at Mount Sinai

Clinicaltrials.gov

Modulating Early Life Microbiome Through Dietary Intervention in...

The MELODY Trial: Modulating Early Life Microbiome through Dietary Intervention in Crohn's Disease, will test whether a non-invasive dietary intervention during pregnancy can improve the gut microbiota...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

University of Massachusetts, Worcester

Clinicaltrials.gov

A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction...

The primary purpose of this study is to evaluate the efficacy and safety of a single intravenous (IV) re-induction dose of approximately 6 milligram per kilogram (mg/kg) ustekinumab in participants with...

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

Janssen-Cilag Ltd.

Clinicaltrials.gov

A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's...

The purpose of this study is to evaluate the efficacy and safety of V565 in participants with active Crohn's Disease.

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

VHsquared Ltd.

Clinicaltrials.gov

Safety and Efficacy Study of Oral Ferric Maltol Compared to...

The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of...

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

Shield Therapeutics

Clinicaltrials.gov

OTIS Vedolizumab Pregnancy Exposure Registry

The purpose of this study is to assess the prevalence of major structural birth defects in infants of female participants with ulcerative colitis (UC) or Crohn's disease (CD) exposed to vedolizumab during...

Trial Type

Observational

Sponsorship

Takeda

Clinicaltrials.gov

Evaluate if Response to Infliximab or Adalimumab May be Regained With...

The immunogenicity of anti-tumor necrosis factor alpha (anti-TNF) therapy in inflammatory bowel disease (IBD) is an important cause of loss of response to therapy that may lead to escalation of dose or...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Indiana University

Clinicaltrials.gov

Treatment of Perianal Disease Using Adipose-derived Stem Cells

This study will compare healing and surgical outcomes in patients with chronic perianal disease treated with Adipose-derived Stem Cells (ASCs) to outcomes in patients treated in traditional surgical techniques...

Trial Type

Observational

Sponsorship

University of California, San Diego

Clinicaltrials.gov

Effect of SB CD on Chylomicron

It is often suggested that lymphatic vessels are ineffective in transporting cargo in Crohn's disease. Our own work on surgically resected tissue supports this concept (1), but the concept has not been...

Trial Type

Observational

Sponsorship

Washington University School of Medicine

Clinicaltrials.gov

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC)...

The purpose of this study is to evaluate vedolizumab pharmacokinetics (PK), safety and tolerability in pediatric participants with moderately to severely active UC or CD.

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Takeda

Clinicaltrials.gov

Study of the Kono-S Anastomosis Versus the Side-to-side Functional...

This study proposes a randomized prospective study comparing the Kono-S anastomosis to the standard side-to-side anastomosis.This will be a multi-center randomized prospective trial. Patients with Crohn's...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

University of Washington

Clinicaltrials.gov

Safety and Tolerability of Vorinostat for the Treatment of...

Background: Crohn's disease (CD) is an inflammatory bowel disease. It causes inflammation of the gut. Symptoms may include diarrhea, abdominal pain, fatigue, weight loss and malnutrition. CD has no cure, but...

Trial Type

Interventional

Trial Phase

Phase 1/Phase 2

Sponsorship

National Institute of Allergy and Infectious Diseases (NIAID)

Clinicaltrials.gov

Vedolizumab Post Op Study

This is a pilot study that will determine the endoscopic recurrence of Crohn's disease 12 months after curative, resective ileal or ileocolonic surgery in patients receiving post-operative vedolizumab...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Takeda

Clinicaltrials.gov

Stelara Pregnancy Exposure Registry OTIS Autoimmune Diseases in...

The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications...

Trial Type

Observational [Patient Registry]

Sponsorship

Janssen Biotech, Inc.

Clinicaltrials.gov

A Study of the Efficacy and Safety of Guselkumab in Participants With...

The purpose of this program is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.

Trial Type

Interventional

Trial Phase

Phase 2/Phase 3

Sponsorship

Janssen Research & Development, LLC

Clinicaltrials.gov

Pediatric MSC-AFP Sub-study for Crohn's Fistula

The purpose of this study is to determine the safety of using an autologous mesenchymal stromal cell (MSC) coated fistula plug in people with fistulizing Crohn's disease. Autologous means these cells to coat...

Trial Type

Interventional

Trial Phase

Phase 1

Sponsorship

Mayo Clinic

High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade

Description

Criteria

Start Date

Last Updated

Sponsor

Condition Name

Learn about this trial.

Related Trials

Clinicaltrials.gov

Pilot Study of Fundamental Modification of the Gut Microbiota in the...

Clinicaltrials.gov

Triple Combination Therapy in High Risk Crohn's Disease (CD)

Clinicaltrials.gov

Autologous Stem Cell Transplantation for Crohn's Disease

Clinicaltrials.gov

Vedolizumab Subcutaneous Long-Term Open-Label Extension Study

Clinicaltrials.gov

Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason

Clinicaltrials.gov

Fecal Microbial Transplantation in Patients With Crohn's Disease

Clinicaltrials.gov

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

Clinicaltrials.gov

Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the...

Clinicaltrials.gov

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric...

Clinicaltrials.gov

Early MRI Prediction of Crohns

Clinicaltrials.gov

Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to...

Clinicaltrials.gov

Efficacy and Safety of TD-1473 in Crohn's Disease

Clinicaltrials.gov

Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease

Clinicaltrials.gov

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug...

Clinicaltrials.gov

Corticosteroid Dosage for Crohn's Disease Flare

Clinicaltrials.gov

Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E....

Clinicaltrials.gov

Autologous Stem Cell Transplant for Crohn's Disease

Clinicaltrials.gov

Modulating Early Life Microbiome Through Dietary Intervention in...

Clinicaltrials.gov

A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction...

Clinicaltrials.gov

A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's...

Clinicaltrials.gov

Safety and Efficacy Study of Oral Ferric Maltol Compared to...

Clinicaltrials.gov

OTIS Vedolizumab Pregnancy Exposure Registry

Clinicaltrials.gov

Evaluate if Response to Infliximab or Adalimumab May be Regained With...

Clinicaltrials.gov

Treatment of Perianal Disease Using Adipose-derived Stem Cells

Clinicaltrials.gov

Effect of SB CD on Chylomicron

Clinicaltrials.gov

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC)...

Clinicaltrials.gov

Study of the Kono-S Anastomosis Versus the Side-to-side Functional...

Clinicaltrials.gov

Safety and Tolerability of Vorinostat for the Treatment of...

Clinicaltrials.gov

Vedolizumab Post Op Study

Clinicaltrials.gov

Stelara Pregnancy Exposure Registry OTIS Autoimmune Diseases in...

Clinicaltrials.gov

A Study of the Efficacy and Safety of Guselkumab in Participants With...

Clinicaltrials.gov

Pediatric MSC-AFP Sub-study for Crohn's Fistula